speb/financial-data huggingface dataset:
BHE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -854000.00
BHE income_statement (annual, 2025-12-31) — Net Income: 24852000.00
BHE income_statement (quarterly, 2025-12-31) — Net Income: 5973000.00
BHE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 24852000.00
BHE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5973000.00
BHE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 24852000.00
BHE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5973000.00
BHE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 24852000.00
BHE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5973000.00
BHE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 24852000.00
BHE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5973000.00
BHE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 24852000.00
BHE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 5973000.00
BHE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 24852000.00
BHE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5973000.00
BHE cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -2931000.00
BHE income_statement (annual, 2025-12-31) — Net Interest Income: -10606000.00
BHE income_statement (quarterly, 2025-12-31) — Net Interest Income: -2367000.00
BHE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -45096000.00
BHE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -5970000.00
BHE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -45096000.00
BHE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -5970000.00
BHE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -10606000.00
BHE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2367000.00
BHE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -9539000.00
BHE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -98000.00
BHE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1000.00
BHE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
BHE balance_sheet (annual, 2025-12-31) — Net PPE: 326448000.00
BHE balance_sheet (quarterly, 2025-12-31) — Net PPE: 326448000.00
BHE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -34822000.00
BHE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -9736000.00
BHE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 907687000.00
BHE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 907687000.00
BHE balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 34936000.00
BHE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 34936000.00
BHE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 7513000.00
BHE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 7513000.00
BHE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 34936000.00
BHE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 34936000.00
BHE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 7513000.00
BHE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 7513000.00
BHE income_statement (annual, 2025-12-31) — Normalized EBITDA: 158862000.00
BHE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 46094000.00
BHE income_statement (annual, 2025-12-31) — Normalized Income: 48188600.00
BHE income_statement (quarterly, 2025-12-31) — Normalized Income: 17074870.00
BHE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 123964000.00
BHE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 58676000.00
BHE cash_flow (annual, 2025-12-31) — Operating Gains Losses: -2621000.00
BHE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -314000.00
BHE income_statement (annual, 2025-12-31) — Operating Income: 105589000.00
BHE income_statement (quarterly, 2025-12-31) — Operating Income: 34196000.00
BHE income_statement (annual, 2025-12-31) — Operating Revenue: 2659108000.00
BHE income_statement (quarterly, 2025-12-31) — Operating Revenue: 704331000.00
BHE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 35669000.00
BHE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 35669000.00
BHE balance_sheet (annual, 2025-12-31) — Other Current Assets: 69226000.00
BHE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 69226000.00
BHE balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 3750000.00
BHE balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3750000.00
BHE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -8975000.00
BHE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -8975000.00
BHE income_statement (annual, 2025-12-31) — Other Income Expense: -33449000.00
BHE income_statement (quarterly, 2025-12-31) — Other Income Expense: -15886000.00
BHE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 70074000.00
BHE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 70074000.00
BHE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 23307000.00
BHE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 23307000.00
BHE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -3909000.00
BHE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1833000.00
BHE balance_sheet (annual, 2025-12-31) — Other Properties: 102664000.00
BHE balance_sheet (quarterly, 2025-12-31) — Other Properties: 102664000.00
BHE balance_sheet (annual, 2025-12-31) — Other Receivables: 182870000.00
BHE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 182870000.00
BHE balance_sheet (annual, 2025-12-31) — Payables: 410907000.00
BHE balance_sheet (quarterly, 2025-12-31) — Payables: 410907000.00
BHE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 516282000.00
BHE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 516282000.00
BHE balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BHE balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BHE income_statement (annual, 2025-12-31) — Pretax Income: 61534000.00
BHE income_statement (quarterly, 2025-12-31) — Pretax Income: 15943000.00
BHE cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 4000.00
BHE cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
BHE balance_sheet (annual, 2025-12-31) — Properties: 0.00
BHE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BHE cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 298000.00
BHE cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 298000.00
BHE cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -2931000.00
BHE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -35613000.00
BHE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -10438000.00
BHE balance_sheet (annual, 2025-12-31) — Raw Materials: 461134000.00
BHE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 461134000.00
BHE balance_sheet (annual, 2025-12-31) — Receivables: 573971000.00
BHE balance_sheet (quarterly, 2025-12-31) — Receivables: 573971000.00
BHE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 2346231000.00
BHE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 619365000.00
BHE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 47630000.00
BHE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 12001000.00
BHE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -936190000.00
BHE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -163470000.00
BHE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -26848000.00
BHE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -854000.00
BHE balance_sheet (annual, 2025-12-31) — Restricted Cash: 336000.00
BHE balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 336000.00
BHE income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 29540000.00
BHE income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 14053000.00
BHE balance_sheet (annual, 2025-12-31) — Retained Earnings: 568163000.00
BHE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 568163000.00
BHE cash_flow (annual, 2025-12-31) — Sale Of Business: 5056000.00
BHE cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
BHE cash_flow (annual, 2025-12-31) — Sale Of PPE: 791000.00
BHE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 702000.00
BHE income_statement (annual, 2025-12-31) — Selling General And Administration: 159658000.00
BHE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 38769000.00
BHE balance_sheet (annual, 2025-12-31) — Share Issued: 35669000.00
BHE balance_sheet (quarterly, 2025-12-31) — Share Issued: 35669000.00
BHE income_statement (annual, 2025-12-31) — Special Income Charges: -29540000.00
BHE income_statement (quarterly, 2025-12-31) — Special Income Charges: -14053000.00
BHE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 17198000.00
BHE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2121000.00
BHE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1099803000.00
BHE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1099803000.00
BHE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 907687000.00
BHE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 907687000.00
BHE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -6203400.00
BHE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2951130.00
BHE income_statement (annual, 2025-12-31) — Tax Provision: 36682000.00
BHE income_statement (quarterly, 2025-12-31) — Tax Provision: 9970000.00
BHE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
BHE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
BHE balance_sheet (annual, 2025-12-31) — Total Assets: 2071715000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Assets: 2071715000.00
BHE balance_sheet (annual, 2025-12-31) — Total Capitalization: 1306629000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1306629000.00
BHE balance_sheet (annual, 2025-12-31) — Total Debt: 309265000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Debt: 309265000.00
BHE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1099803000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1099803000.00
BHE income_statement (annual, 2025-12-31) — Total Expenses: 2553519000.00
BHE income_statement (quarterly, 2025-12-31) — Total Expenses: 670135000.00
BHE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 971912000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 971912000.00
BHE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 623574000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 623574000.00
BHE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 336335000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 336335000.00
BHE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 76049000.00
BHE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 20143000.00
BHE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 7685000.00
BHE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 7685000.00
BHE income_statement (annual, 2025-12-31) — Total Unusual Items: -29540000.00
BHE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -14053000.00
BHE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -29540000.00
BHE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -14053000.00
BHE balance_sheet (annual, 2025-12-31) — Work In Process: 17193000.00
BHE balance_sheet (quarterly, 2025-12-31) — Work In Process: 17193000.00
BHE balance_sheet (annual, 2025-12-31) — Working Capital: 812564000.00
BHE balance_sheet (quarterly, 2025-12-31) — Working Capital: 812564000.00
BHE income_statement (quarterly, 2026-03-31) — +Operating Expense: 43613000.00
BHE income_statement (quarterly, 2026-03-31) — +Total Revenue: 677280000.00
BHE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 451146000.00
BHE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 375902000.00
BHE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 533114000.00
BHE balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -438000.00
BHE income_statement (quarterly, 2026-03-31) — Amortization: 1204000.00
BHE cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 2518000.00
BHE cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 2518000.00
BHE income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 1204000.00
BHE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 35766000.00
BHE income_statement (quarterly, 2026-03-31) — Basic EPS: 0.36
BHE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 322400000.00
BHE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -18270000.00
BHE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -2254000.00
BHE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 99546000.00
BHE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3588000.00
BHE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 324908000.00
BHE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 324908000.00
BHE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -6062000.00
BHE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -25900000.00
BHE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -16098000.00
BHE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 47028000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 42323000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -8399000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Inventory: -25558000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -26000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -3021000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Payable: 42323000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 33924000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 6375000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Receivables: 6106000.00
BHE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 17800000.00
BHE cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 14170000.00
BHE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 5030000.00
BHE balance_sheet (quarterly, 2026-03-31) — Common Stock: 3588000.00
BHE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1096501000.00
BHE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -5799000.00
BHE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 608046000.00
BHE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 97282000.00
BHE balance_sheet (quarterly, 2026-03-31) — Current Assets: 1459985000.00
BHE balance_sheet (quarterly, 2026-03-31) — Current Debt: 3750000.00
BHE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3750000.00
BHE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 110966000.00
BHE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 110966000.00
BHE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 669221000.00
BHE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -668000.00
BHE cash_flow (quarterly, 2026-03-31) — Deferred Tax: -668000.00
BHE cash_flow (quarterly, 2026-03-31) — Depreciation: 9384000.00
BHE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 11902000.00
BHE income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 1204000.00
BHE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 11902000.00
BHE income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1204000.00
BHE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 36276000.00
BHE income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.36
BHE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 13023000.00
BHE income_statement (quarterly, 2026-03-31) — EBIT: 22071000.00
BHE income_statement (quarterly, 2026-03-31) — EBITDA: 33973000.00
BHE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2189000.00
BHE cash_flow (quarterly, 2026-03-31) — End Cash Position: 325241000.00
BHE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -25900000.00
BHE balance_sheet (quarterly, 2026-03-31) — Finished Goods: 2727000.00
BHE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 28758000.00
BHE cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -31000.00
BHE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -10700000.00
BHE balance_sheet (quarterly, 2026-03-31) — Goodwill: 192116000.00
BHE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 192116000.00
BHE balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 376340000.00
BHE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 339811000.00
BHE income_statement (quarterly, 2026-03-31) — Gross Profit: 69234000.00
BHE cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 4478000.00
BHE balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 6077000.00
BHE income_statement (quarterly, 2026-03-31) — Interest Expense: 3649000.00
BHE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3649000.00
BHE income_statement (quarterly, 2026-03-31) — Interest Income: 1900000.00
BHE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1900000.00
BHE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 3494000.00
BHE balance_sheet (quarterly, 2026-03-31) — Inventory: 507447000.00
BHE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1301281000.00
BHE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -16098000.00
BHE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 113000000.00
BHE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 99546000.00
BHE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 201030000.00
BHE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 300576000.00
BHE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 113000000.00
BHE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -118938000.00
BHE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -5799000.00
BHE income_statement (quarterly, 2026-03-31) — Net Income: 13023000.00
BHE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 13023000.00
BHE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 13023000.00
BHE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 13023000.00
BHE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 13023000.00
BHE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 13023000.00
BHE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 13023000.00
BHE income_statement (quarterly, 2026-03-31) — Net Interest Income: -1749000.00
BHE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -5938000.00
BHE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -5938000.00
BHE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1749000.00
BHE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -8101000.00
BHE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 2141000.00
BHE balance_sheet (quarterly, 2026-03-31) — Net PPE: 339811000.00
BHE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -15985000.00
BHE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 904385000.00
BHE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 35508000.00
BHE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 7587000.00
BHE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 35508000.00
BHE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 7587000.00
BHE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 37720000.00
BHE income_statement (quarterly, 2026-03-31) — Normalized Income: 15672129.00
BHE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 47028000.00
BHE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -430000.00
BHE income_statement (quarterly, 2026-03-31) — Operating Income: 25621000.00
BHE income_statement (quarterly, 2026-03-31) — Operating Revenue: 677280000.00
BHE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 35879000.00
BHE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 60461000.00
BHE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3750000.00
BHE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -10700000.00
BHE income_statement (quarterly, 2026-03-31) — Other Income Expense: -5450000.00
BHE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 68773000.00
BHE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 22308000.00
BHE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1703000.00
BHE balance_sheet (quarterly, 2026-03-31) — Other Properties: 339811000.00
BHE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 190934000.00
BHE balance_sheet (quarterly, 2026-03-31) — Payables: 457223000.00
BHE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 554505000.00
BHE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BHE income_statement (quarterly, 2026-03-31) — Pretax Income: 18422000.00
BHE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
BHE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -16016000.00
BHE balance_sheet (quarterly, 2026-03-31) — Raw Materials: 485778000.00
BHE balance_sheet (quarterly, 2026-03-31) — Receivables: 566836000.00
BHE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 597348000.00
BHE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 11902000.00
BHE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -118938000.00
BHE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -5799000.00
BHE balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 333000.00
BHE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 3747000.00
BHE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 570499000.00
BHE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 31000.00
BHE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 42409000.00
BHE balance_sheet (quarterly, 2026-03-31) — Share Issued: 35879000.00
BHE income_statement (quarterly, 2026-03-31) — Special Income Charges: -3747000.00
BHE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 5401000.00
BHE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1096501000.00
BHE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 904385000.00
BHE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -1097871.00
BHE income_statement (quarterly, 2026-03-31) — Tax Provision: 5399000.00
BHE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
BHE balance_sheet (quarterly, 2026-03-31) — Total Assets: 2096193000.00
BHE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1297531000.00
BHE balance_sheet (quarterly, 2026-03-31) — Total Debt: 304326000.00
BHE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1096501000.00
BHE income_statement (quarterly, 2026-03-31) — Total Expenses: 651659000.00
BHE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 999692000.00
BHE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 636208000.00
BHE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 330471000.00
BHE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 21874000.00
BHE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 6077000.00
BHE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -3747000.00
BHE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -3747000.00
BHE balance_sheet (quarterly, 2026-03-31) — Work In Process: 18942000.00
BHE balance_sheet (quarterly, 2026-03-31) — Working Capital: 790764000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -39945500000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 378700000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -5934000000.00
BHEL.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 182700000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 17452800000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 282000000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 7044200000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 18100000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 32900000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 6079400000.00
BHEL.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -170800000.00
BHEL.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 1283300000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 36181500000.00
BHEL.NS income_statement (annual, 2022-03-31) — Interest Income: 3027900000.00
BHEL.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 3027900000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Inventories Adjustments Allowances: -7470800000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Investments In Other Ventures Under Equity Method: 2018600000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1465700000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 35246600000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
BHEL.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 100000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 24191000000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 2862000000.00
BHEL.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 72800000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 1675800000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Other Payable: 13856400000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 93700300000.00
BHEL.NS income_statement (annual, 2022-03-31) — Other Special Charges: -2127600000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 6703700000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
BHEL.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -12511200000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 31972300000.00
BHEL.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 609900000.00
BHEL.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 609900000.00
BHEL.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -875300000.00
BHEL.NS income_statement (annual, 2022-03-31) — Research And Development: 249300000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 98400000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -39567000000.00
BHEL.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 2431700000.00
BHEL.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 3715000000.00
BHEL.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -875300000.00
BHEL.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 935700000.00
BHEL.NS balance_sheet (annual, 2022-03-31) — Work In Process: 33345400000.00
BHEL.NS income_statement (annual, 2023-03-31) — +Operating Expense: 57390800000.00
BHEL.NS income_statement (annual, 2023-03-31) — +Total Revenue: 221363000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 98958300000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 31283500000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -42122300000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 378700000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -6726800000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 140900000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 870900000.00
BHEL.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 3482100000.00
BHEL.NS income_statement (annual, 2023-03-31) — Basic EPS: 1.88
BHEL.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 7326200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 18257100000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1884000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 685100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 6964100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 14491100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 63014500000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -1391800000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 14490900000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -1924000000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -944000000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Change In Payable: 19755700000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -24854000000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -7966300000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 8287200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Common Stock: 6964100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 243782600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 3618800000.00
BHEL.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 163007200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Current Assets: 290945000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 347600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Current Debt: 53850000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 54197600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 234795500000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 27966300000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Depreciation: 2462500000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 2603400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 2603400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 2603400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 3482100000.00
BHEL.NS income_statement (annual, 2023-03-31) — Diluted EPS: 1.88
BHEL.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 6374400000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 19100000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 261800000.00
BHEL.NS income_statement (annual, 2023-03-31) — EBIT: 12365500000.00
BHEL.NS income_statement (annual, 2023-03-31) — EBITDA: 14968900000.00
BHEL.NS cash_flow (annual, 2023-03-31) — End Cash Position: 15613400000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 31300000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 889600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 5117700000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -9291000000.00
BHEL.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 1557000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 765000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 38010300000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 69828500000.00
BHEL.NS income_statement (annual, 2023-03-31) — Gross Profit: 58355800000.00
BHEL.NS income_statement (annual, 2023-03-31) — Interest Expense: 5209400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 5209400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Interest Income: 4211200000.00
BHEL.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 4211200000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -3620900000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 2507200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Inventories Adjustments Allowances: -7437900000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Inventory: 67559000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 297632600000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 14804600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 31300000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Investments In Other Ventures Under Equity Method: 2322900000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 0.00
BHEL.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 6400000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1475700000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 337500000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 337500000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 2322900000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 41010200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 36580200000.00
BHEL.NS income_statement (annual, 2023-03-31) — Minority Interests: -166800000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Net Debt: 39358900000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -4018500000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Income: 6374400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 6374400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 6541200000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 6374400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 6374400000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 7156100000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 6541200000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Interest Income: -1905800000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 13842000000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 6400000000.00
BHEL.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1905800000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Net PPE: 27706200000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1806400000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 6400000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 243017600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 28529100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 42465400000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 2401100000.00
BHEL.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 12280900000.00
BHEL.NS income_statement (annual, 2023-03-31) — Normalized Income: 3917370947.86
BHEL.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -7407000000.00
BHEL.NS income_statement (annual, 2023-03-31) — Operating Income: 965000000.00
BHEL.NS income_statement (annual, 2023-03-31) — Operating Revenue: 221363000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 3482063355.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 130508400000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 39622900000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 261316200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 765000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 2730800000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 583900000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 193001400000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 100000.00
BHEL.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 254300000.00
BHEL.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2858600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Payable: 16551800000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Properties: 9896700000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 106367100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 48523400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Other Special Charges: -2435400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Payables: 115529200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 5626800000.00
BHEL.NS income_statement (annual, 2023-03-31) — Pretax Income: 7156100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
BHEL.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -6309600000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1884000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 32320900000.00
BHEL.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 163007200000.00
BHEL.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 2603400000.00
BHEL.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 608600000.00
BHEL.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 608600000.00
BHEL.NS income_statement (annual, 2023-03-31) — Research And Development: 242800000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 3966200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -65331000000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 13842000000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 77600000.00
BHEL.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 2531700000.00
BHEL.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 4088700000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Share Issued: 3482063355.00
BHEL.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 6400000000.00
BHEL.NS income_statement (annual, 2023-03-31) — Special Income Charges: 2435400000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 243782600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 243017600000.00
BHEL.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 230970947.86
BHEL.NS income_statement (annual, 2023-03-31) — Tax Provision: 614900000.00
BHEL.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.09
BHEL.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 13127900000.00
BHEL.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: 1104200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Total Assets: 569200200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 243782600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Total Debt: 54535100000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 243782600000.00
BHEL.NS income_statement (annual, 2023-03-31) — Total Expenses: 220398000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 325417600000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 278255200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 90622100000.00
BHEL.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 907600000.00
BHEL.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 2688000000.00
BHEL.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 2688000000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 20659200000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Trading Securities: 0.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Work In Process: 34827500000.00
BHEL.NS balance_sheet (annual, 2023-03-31) — Working Capital: 56149500000.00
BHEL.NS income_statement (annual, 2024-03-31) — +Operating Expense: 59336100000.00
BHEL.NS income_statement (annual, 2024-03-31) — +Total Revenue: 229205200000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 85393800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 47853800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -43863300000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 378700000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -11040000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Amortization: 152400000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 152400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 2072900000.00
BHEL.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 3482100000.00
BHEL.NS income_statement (annual, 2024-03-31) — Basic EPS: 0.81
BHEL.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 15613400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 19815700000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2325000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 484600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 6964100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 17188600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 54585100000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -1394500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 17188600000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -5030400000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 13980200000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Change In Payable: -11194300000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -32201600000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -34446100000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 2737000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Common Stock: 6964100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 244386500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 2846200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 168071100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Current Assets: 345421100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 249100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Current Debt: 88080000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 88329100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 252472400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 23182700000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Depreciation: 2336600000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 2489000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 2489000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 2336600000.00
BHEL.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 3482100000.00
BHEL.NS income_statement (annual, 2024-03-31) — Diluted EPS: 0.81
BHEL.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 2822200000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 17400000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 416500000.00
BHEL.NS income_statement (annual, 2024-03-31) — EBIT: 9739100000.00
BHEL.NS income_statement (annual, 2024-03-31) — EBITDA: 12228100000.00
BHEL.NS cash_flow (annual, 2024-03-31) — End Cash Position: 18350400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 11900000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 26557400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 5034900000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -39454000000.00
BHEL.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1948700000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 894000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 58893800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 71816500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Gross Profit: 61134100000.00
BHEL.NS income_statement (annual, 2024-03-31) — Interest Expense: 7312500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 7312500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Interest Income: 4937800000.00
BHEL.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 4937800000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -5934900000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 3993000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Inventories Adjustments Allowances: -7821600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Inventory: 72205700000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 332466500000.00